Sean J Barbour Selected Research

Sean J Barbour Research Topics

Disease

16	Proteinuria 04/2024 - 01/2012
13	Membranous Glomerulonephritis (Membranous Nephropathy) 04/2024 - 06/2014
8	IGA Glomerulonephritis (IGA Nephropathy) 01/2024 - 06/2012
5	Lupus Nephritis 12/2023 - 01/2019
4	Focal Segmental Glomerulosclerosis (Glomerulosclerosis, Focal) 12/2023 - 01/2019
4	Kidney Diseases (Kidney Disease) 10/2023 - 01/2020
4	Chronic Renal Insufficiency 01/2022 - 01/2019
2	Lipoid Nephrosis (Glomerulonephritis, Minimal Change) 12/2023 - 12/2022
2	Renal Insufficiency (Renal Failure) 01/2023 - 01/2022
2	Nephrotic Syndrome (Syndrome, Nephrotic) 01/2022 - 10/2020
2	Chronic Kidney Failure (Chronic Renal Failure) 01/2022 - 11/2013
2	Disease Progression 01/2021 - 01/2019
2	Diabetic Nephropathies (Diabetic Nephropathy) 01/2021 - 01/2016
2	Glomerulonephritis 01/2019 - 08/2011
2	Neoplasms (Cancer) 01/2012 - 08/2011
1	Inflammation (Inflammations) 01/2024
1	Nephritis 12/2023
1	Membranoproliferative Glomerulonephritis (Membranoproliferative Glomerulonephritis, Type II) 01/2022
1	Lipoprotein Glomerulopathy 01/2022
1	Type 2 Diabetes Mellitus (MODY) 01/2021
1	Benign Familial Hematuria 01/2021
1	Nephrosis 10/2020
1	Heart Failure 01/2019
1	Unstable Angina 01/2019
1	Myocardial Infarction 01/2019
1	Body Weight (Weight, Body) 01/2019
1	Vasculitis (Vasculitides) 01/2016
1	Lymphoma (Lymphomas) 01/2016
1	Immunoglobulin G4-Related Disease 01/2016
1	Hemorrhage 06/2014
1	Hypoalbuminemia 06/2014
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 08/2011
1	Apnea 06/2004
1	Respiratory Insufficiency (Respiratory Failure) 06/2004

Drug/Important Bio-Agent (IBA)

5	Rituximab (Mabthera)FDA Link 04/2024 - 01/2015
5	Biomarkers (Surrogate Marker)IBA 01/2022 - 06/2012
4	Cyclosporine (Ciclosporin)FDA LinkGeneric 04/2024 - 01/2015
4	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 12/2023 - 01/2019
3	Proteins (Proteins, Gene)FDA Link 01/2024 - 06/2012
3	Antigen-Antibody Complex (Immune Complex)IBA 12/2023 - 01/2016
3	DiamondIBA 01/2022 - 01/2020
3	dapagliflozinIBA 01/2022 - 01/2020
2	AutoantibodiesIBA 12/2023 - 11/2023
2	AntigensIBA 12/2023 - 11/2023
2	AlbuminsIBA 10/2023 - 06/2014
2	SteroidsIBA 01/2023 - 01/2021
2	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 01/2021
2	SodiumIBA 01/2022 - 01/2021
2	Monoclonal AntibodiesIBA 01/2022 - 01/2015
2	Immunoglobulin G (IgG)IBA 01/2016 - 08/2011
2	Serum AlbuminIBA 06/2014 - 01/2012
1	Complement C5 (Complement 5)IBA 01/2024
1	Complement System Proteins (Complement)IBA 01/2024
1	Phospholipase A2 ReceptorsIBA 10/2023
1	AntibodiesIBA 10/2023
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2023
1	Budesonide (Pulmicort)FDA LinkGeneric 01/2023
1	VaccinesIBA 12/2022
1	CD20 AntigensIBA 01/2022
1	LipidsIBA 01/2022
1	Lipoproteins (Lipoprotein)IBA 01/2022
1	Complement C3 (C3 Complement)IBA 01/2022
1	Apolipoproteins E (ApoE)IBA 01/2022
1	ApolipoproteinsIBA 01/2022
1	Immunoglobulins (Immunoglobulin)IBA 01/2022
1	Immunosuppressive Agents (Immunosuppressants)IBA 01/2022
1	MicroRNAs (MicroRNA)IBA 01/2021
1	SymportersIBA 01/2021
1	Puromycin AminonucleosideIBA 10/2020
1	podocalyxinIBA 10/2020
1	p38 Mitogen-Activated Protein KinasesIBA 08/2020
1	6- (5- ((cyclopropylamino)carbonyl)- 3- fluoro- 2- methylphenyl)- N- (2,2- dimethylprpyl)- 3- pyridinecarboxamideIBA 08/2020
1	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2020
1	pro-brain natriuretic peptide (1-76)IBA 01/2019
1	AngiotensinsIBA 01/2019
1	CreatinineIBA 01/2019
1	TinIBA 01/2016
1	ElementsIBA 12/2015
1	Angiotensin IIIBA 01/2015
1	Immunoglobulin A (IgA)IBA 06/2012
1	Remifentanil (Ultiva)FDA Link 06/2004
1	Opioid Analgesics (Opioids)IBA 06/2004

Therapy/Procedure

1	Therapeutics 10/2020
1	Transplantation 11/2013